O-Cal FA Multivitamin is commonly used as a supportive measure for nutritional deficiencies, which may manifest as systemic symptoms and conditions that interfere with daily functioning. The components of this multivitamin are relevant for managing symptoms related to blood and cell function. It is considered relevant in conditions involving nutrient deficits, such as anemia, and may be applied in cases presenting with weakness, fatigue, and the need for supportive maintenance of skeletal and neurological systems.

This supplement is applied in contexts marked by increased physiological strain, particularly during pregnancy and lactation, to bridge chronic nutritional gaps arising from restricted diets, and to address symptoms related to pallor or bone density risk. The multivitamin may assist with managing symptoms related to weakness and fatigue, which contributes to easing the overall symptom load and supports general well-being.

---

Quick Fact: Relief for Nutritional Deficits

Feature	Therapeutic Benefit
Symptom Cluster	Deficiency-related fatigue and weakness
Clinical Context	High-demand states (pregnancy, lactation)
Primary Benefit	Supports blood and bone cell formation

---

Regulatory References

1. NIH MedlinePlus Medical Encyclopedia

Who Can and Cannot Use O-Cal FA Multivitamin?

This section summarizes the official population eligibility and non-eligibility rules for O-Cal FA Multivitamin, strictly as documented in governmental regulatory labeling (e.g., FDA DailyMed).

---

Populations Prohibited from Use (Contraindicated)

Use of O-Cal FA Multivitamin is contraindicated and must be avoided in several patient groups, primarily due to the risk associated with its Iron component.

• Patients with a known hypersensitivity or allergy to any ingredient in the formulation.
• Patients diagnosed with conditions involving iron overload, specifically hemochromatosis or hemosiderosis.
• Patients with hemolytic anemias, where additional iron supplementation is typically harmful.

---

Established and Restricted Use

Established Use: The multivitamin is officially documented as an established nutritional supplement for women prior to and throughout pregnancy, and during the postnatal period, including both lactating and non-lactating mothers.

Restricted Populations:

• Pediatric Use: Safety and effectiveness have not been established in pediatric populations, and a regulatory warning exists against accidental overdose in children under 6 years of age.
• Geriatric Use: Safety and effectiveness have not been established in the elderly population.
• Conditional Use: The folic acid component requires caution in patients with undiagnosed pernicious anemia (Vitamin B12 deficiency), as it may mask the blood-related symptoms while neurological damage progresses.

Interactions with other medicines and products

Official regulatory information describes that the interaction profile of O-Cal FA Multivitamin is primarily driven by the physicochemical properties of its mineral components (Iron and Calcium) and the biochemical activity of its key vitamins (Folic Acid and Pyridoxine).

---

Documented Exposure-Altering Interactions

The multivitamin’s Iron and Calcium components can cause reduced systemic absorption of co-administered oral medications through chelation in the gastrointestinal tract. Regulatory documents mandate timing separation for administration with:

• Quinolone and Tetracycline Antibiotics
• Bisphosphonates (e.g., Alendronate)
• Thyroid Products (e.g., Levothyroxine)
• HIV Integrase Inhibitors (e.g., Dolutegravir)

---

Pharmacodynamic and Substance Interactions

The Folic Acid component is documented to decrease the therapeutic effect of Methotrexate, representing a pharmacodynamic conflict. Similarly, Pyridoxine (Vitamin B6) may reduce the efficacy of Levodopa by increasing its peripheral metabolism. Alcohol consumption is documented to reduce the absorption and increase the elimination of Folic Acid. Furthermore, regulatory notes indicate that the Cyanocobalamin (Vitamin B12) component contains Aluminum, which may accumulate to toxic levels with prolonged use in patients with impaired kidney function.

Essential Cofactors for DNA and Red Blood Cell Synthesis

This mechanism centers on the role of Folic Acid (B9) and Iron as key biochemical cofactors. Folic Acid is essential for the nucleic acid synthesis pathway, specifically the provision of precursors (purines and pyrimidines) required for cell division. Iron is incorporated into the heme prosthetic group of hemoglobin. This combined action drives the cascade necessary for erythropoiesis and supplies substrates for cells undergoing rapid turnover. The consequence is the molecular stabilization required for proper cellular replication.

Modulation of Calcium Homeostasis and Structural Integrity

The action involves Calcium as a structural component and Vitamin D as a gene-modulating hormone precursor. Vitamin D engages nuclear receptors to enhance the active intestinal absorption of Calcium. This interaction targets the skeletal regulatory axis, influencing systemic mineral gradients, which is required for appropriate excitation-contraction coupling and action potential generation in excitable tissues.

Support for Cellular Protection and Redox Balance

Vitamins C and E function as exogenous antioxidants and electron donors. Their mechanism involves directly neutralizing reactive oxygen species (ROS) and free radicals in the aqueous and lipid domains of the cell. This chemical interaction modulates the cellular redox state, and the consequence is the chemical stabilization of cellular lipids and proteins required for sustained structural integrity.

O-Cal FA Multivitamin is used according to specific administration protocols. The product is administered via the oral route and is formulated as an Oral Tablet (caplet).

The standardized dosing regimen dictates the use of one tablet daily. This established Once Daily frequency means the full dose is taken every 24 hours. The tablet must be swallowed whole, typically with water, as the caplet form is unscored and not intended for splitting or crushing.

Target Population and Duration

The administration protocol is designed for continuous supplementation linked to specific physiological periods. This multivitamin is primarily indicated for use prior to and through pregnancy and during the postnatal period, including for both lactating and non-lactating mothers. The course of use is continuous over the duration of these high-demand states.

A specific administration constraint relates to the formulation's 1 mg Folic Acid strength. This dose level requires professional clinical consideration regarding potential undiagnosed pernicious anemia, as the dose can affect hematological signs. The overall administration protocol is strictly procedural, defining the precise form, frequency, and duration of use.

Evidence for Nutritional Support in Pregnancy and High-Demand States

The combination of micronutrients found in O-Cal FA Multivitamin includes components that were evaluated in research for nutritional support during periods of high physiological demand, such as pregnancy and lactation. The research, often comprised of Randomized Controlled Trials (RCTs) and systematic reviews, explored whether the use of these components could influence the mother's nutritional status and infant health markers.

Studies observed newborn health outcomes, including birth weight and gestational age. Findings describe patterns such as measurements of changes in maternal micronutrient status, and some trials report patterns related to the observed incidence of certain adverse birth outcomes when multiple micronutrients were used instead of iron-folic acid alone. However, long-term outcomes concerning the sustained growth or neurodevelopment of children are not fully established, and reported patterns were often most noticeable in populations with poorer baseline nutritional intake.

---

Studies Addressing Specific Nutritional Deficits

The components were also evaluated in research for their role in addressing generalized nutritional deficits related to blood and bone health. Research explored whether the use of these components could influence outcomes related to systemic or functional imbalance, such as shifts in hematological parameters (for anemia) and changes in Bone Mineral Density (BMD) (for skeletal support).

Research describes patterns related to changes in blood biomarker levels following the evaluation of low nutrient status. For bone health, long-term studies show patterns related to the incidence of fractures observed in specific high-risk groups, particularly with the combination of Calcium and Vitamin D. However, the link between those lab changes and shifts in overall, non-specific patient-reported outcomes (such as generalized fatigue) is limited.

---

What Remains Uncertain

One main research limitation is that existing randomized trials often focus on one or two nutrients rather than the entire comprehensive formula; thus, comparative evidence for the full, specific combination is lacking. Furthermore, while studies help show what has been observed so far, the application of general multivitamin findings to specific long-term outcomes (such as prevention of chronic disease) in the general healthy population has low certainty.

Key Studies & References Folic acid and vitamin B12 supplementation in anaemic patients: A literature review

Common questions about O-Cal FA Multivitamin (FAQ)

Q: What is O-Cal FA Multivitamin?

A: O-Cal FA Multivitamin is a prescription dietary supplement formulated to provide essential vitamins and minerals, including calcium, vitamin D, and folic acid. It is often prescribed to help manage dietary needs in certain populations.

Q: How does this supplement function in the body?

A: The components of the supplement, such as calcium and vitamin D, are known to support bone health. Folic acid is a B-vitamin involved in cellular processes. The combination is intended to address specific nutritional requirements as directed by a healthcare provider.

Q: What are the main ingredients in O-Cal FA Multivitamin?

A: The primary active ingredients typically include Calcium Carbonate, Cholecalciferol (Vitamin D3), and Folic Acid. Inactive ingredients may vary by manufacturer.

Q: Can O-Cal FA Multivitamin be taken with other medications?

A: It is important to discuss all current medications and supplements with a healthcare professional before starting O-Cal FA Multivitamin. Certain components, like calcium, may interact with the absorption or effectiveness of some prescription drugs. A pharmacist or physician can provide personalized advice.

How to Store and Dispose of O-Cal FA Multivitamin

Storage Requirements

O-Cal FA Multivitamin must be stored at Controlled Room Temperature (20 C to 25 C), with permissible short-term excursions up to 30 C. To preserve stability, the product must be stored in its original container, which must be kept tightly closed and be light-resistant. It is mandatory to protect the multivitamin from excess heat and moisture.

Child Safety and Disposal

Due to the significant risk of accidental iron overdose, the product must be stored out of the sight and reach of children at all times. Unused or expired O-Cal FA Multivitamin must be disposed of according to local regulations for discarding pharmaceuticals.